EMMAUS LIFE SCIENCES, INC. (EMMA) Free cash flow 2017–2025
EMMAUS LIFE SCIENCES, INC. (EMMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12,000FY2025 · since FY2017: -$4.9M → -$12,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12,000 | +99.5% |
| FY2024 | -$2.3M | -51.2% |
| FY2023 | -$1.5M | +70.2% |
| FY2022 | -$5.1M | -284.3% |
| FY2021 | -$1.3M | +46.2% |
| FY2020 | -$2.5M | +46.2% |
| FY2019 | -$4.6M | +20.0% |
| FY2018 | -$5.7M | -16.4% |
| FY2017 | -$4.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EMMA financial trends
EMMA RevenueEMMA Net incomeEMMA Net marginEMMA Gross profitEMMA Gross marginEMMA Operating incomeEMMA Operating marginEMMA Operating cash flowEMMA Capital expendituresEMMA Return on equityEMMA Stock buybacksEMMA Dividends paidEMMA Total assetsEMMA Total liabilitiesEMMA Shareholders’ equityEMMA overview →